(Total Views: 700)
Posted On: 12/27/2020 12:20:55 PM
Post# of 148908
Re: Goosebumps #69813
Why will CYDYshare price go up on Monday?
1) because a lot of folks think it will go up Monday
2) because a kind of confusing PR came out, that sounds like really good news
3) because many investors are impulsively waiting for any overdue good news
4) because it appears obvious that doctors will very soon be able to access leronlimab under a "continuation" of eIND investigational drug trials
5) because it appears obvious that doctors at our trial sites will be able to give leronlimab to an unlimited number of s/c patients under an "open label extension" of our Phase III s/c leronlimab trial
6) because investors are anticipating multiple catalysts and a positive PR sparks an excitement about these catalysts
7) because investors ARE VERY OPTIMISTIC about reports which will be coming out soon, describing s/c covid patients recovering quickly, 3 to 5 days, after being given shots of leronlimab, under the eIND and "continuation of the Phase III s/c trial"
What could possibly hinder or prevent a rise in share price on Monday?
Not a common short attack, but, a large and coordinated short attack, yes could hinder a Monday rise in sp. Shorts would not be so wise in attacking us, but they ain't known to be very wise.
1) because a lot of folks think it will go up Monday
2) because a kind of confusing PR came out, that sounds like really good news
3) because many investors are impulsively waiting for any overdue good news
4) because it appears obvious that doctors will very soon be able to access leronlimab under a "continuation" of eIND investigational drug trials
5) because it appears obvious that doctors at our trial sites will be able to give leronlimab to an unlimited number of s/c patients under an "open label extension" of our Phase III s/c leronlimab trial
6) because investors are anticipating multiple catalysts and a positive PR sparks an excitement about these catalysts
7) because investors ARE VERY OPTIMISTIC about reports which will be coming out soon, describing s/c covid patients recovering quickly, 3 to 5 days, after being given shots of leronlimab, under the eIND and "continuation of the Phase III s/c trial"
What could possibly hinder or prevent a rise in share price on Monday?
Not a common short attack, but, a large and coordinated short attack, yes could hinder a Monday rise in sp. Shorts would not be so wise in attacking us, but they ain't known to be very wise.
(1)
(0)Scroll down for more posts ▼
